Protein crosslinking in assembly and remodelling of extracellular matrices: The role of transglutaminases

Connective Tissue Research

Volumn 41, Issue 1, 2000, Pages 1-27

  Aeschlimann, Daniel ^a,c   Thomazy, Vilmos ^b  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

^c CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Crosslinking; Matrix proteins; Pathology; Transglutaminase

Indexed keywords

AMYLOID BETA PROTEIN; BLOOD CLOTTING FACTOR 13; CALCIUM; COLLAGEN; CYTOKINE; DERMATAN SULFATE; DNA; ENTACTIN; FIBRIN GLUE; FIBRONECTIN; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANOSINE TRIPHOSPHATE; HYALURONIC ACID; INTERLEUKIN 6; LIPOPROTEIN A; MACROGOL; OSTEONECTIN; PLASMIN; PLASMINOGEN; POLYLYSINE; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; PROTEOGLYCAN; RETINOID; TAU PROTEIN; TRANSFORMING GROWTH FACTOR BETA; VITRONECTIN; VON WILLEBRAND FACTOR;

CELIAC DISEASE; DEGENERATIVE DISEASE; ENZYME ACTIVATION; ENZYME ACTIVITY; EXTRACELLULAR MATRIX; FIBROSIS; GENE; HUMAN; INFLAMMATION; METASTASIS; NONHUMAN; PROTEIN CROSS LINKING; SHORT SURVEY; WOUND HEALING;

EID: 0034093354     PISSN: 03008207     EISSN: None     Source Type: Journal    
DOI: 10.3109/03008200009005638     Document Type: Short Survey

References (181)

1. Folk, J.E. and Finlayson, J.S. (1977). The ε-(γ-glutamyl)-lysine crosslink and the catalytic role of transglutaminases. Adv. Protein Chem., 31, 1-133.
2. Lorand, L. and Conrad, S.M. (1984). Transglutaminases. Mol. Cell Biochem., 58, 9-35.
3. Parameswaran, K.N., Cheng, X.-F., Chen, E.C., Velasco, P.T., Wilson, J.H. and Lorand, L. (1997). Hydrolysis of γ:ε isopeptides by cytosolic transglutaminases and by coagulation factor XIIIa. J. Biol. Chem., 272, 10 311-10 317.
4. Loewy, A.G., Santer, U.V., Wieczorek, M., Blodgett, J.K., Jones, S.W. and Cheronis, J.C. (1993). Purification and characterization of a novel zinc-proteinase from cultures of Aeromonas hydrophila. J. Biol. Chem., 268, 9071-9078.
5. Eitan, S. and Schwartz, M. (1993). A transglutaminase that converts interleukin-2 into a factor cytotoxic to oligodendrocytes. Science, 261, 106-108.
6. Kojima, S., Nara, K. and Rifkin, D.B. (1993). Requirement for transglutaminase in the activation of latent transforming growth factor-β in bovine endothelial cells. J. Cell Biol., 121, 439-448.
7. Nunes, I., Gleizes, P.-E., Metz, C.N. and Rifkin, D.B. (1997). Latent transforming growth factor-β binding protein domains involved in activation and transglutaminase-dependent crosslinking of latent transforming growth factor-β J. Cell Biol., 136, 1151-1163.
8. Kojima, S., Inui, T., Muramatsu, H., Suzuki, Y., Kadomatsu, K., Yoshizawa, M., Hirose, S., Kimura, T., Sakakibara, S. and Muramatsu, T. (1997). Dimerization of midkine by tissue transglutaminase and its functional implications. J. Biol. Chem., 272, 9410-9416.
9. Mahoney, S.-A., Perry, M., Seddon, A., Bohlen, P. and Haynes, L. (1996). Transglutaminase forms midkine homodimers in cerebellar neurons and modulates the neurite-outgrowth response. Biochem. Biophys. Res. Commun., 224, 147-152.
10. 2-plasmin inhibitor to fibrin catalyzed by activated fibrin-stabilizing factor. J. Biol. Chem., 257, 14 767-14 772.
11. Mycek, M.J. and Waelsch, H. (1960). The enzymatic deamidation of proteins. J. Biol. Chem., 235, 3513-3517.
12. Molberg, O., McAdam, S.N., Körner, R., Quarsten, H., Kristiansen, C., Madsen, L., Fugger, L., Scott, H., Norén, O., Roepstorff, P., Lundin, K.E.A., Sjöström, H. and Sollid, L.M. (1998). Tissue transglutaminase selectively modifies gliadin peptides that are recognized by gut-derived T cells in celiac disease. Nature Med., 4, 713-717.
13. Van de Wal, Y., Kooy, Y., van Veelen, P., Peña, S., Mearin, L., Papadopoulos, G. and Koning, F. (1998). Selective deamidation by tissue transglutaminase strongly enhances gliadin-specific T cell reactivity. J. Immunol., 161, 1585-1588.
14. Aeschlimann, D. and Paulsson, M. (1994). Transglutaminases: Protein crosslinking enzymes in tissues and body fluids. Thromb. Haemostasis, 71, 402-415.
15. Aeschlimann, D., Koeller, M.-K., Allen-Hoffmann, B.L. and Mosher, D.F. (1998). Isolation of a cDNA encoding a novel member of the transglutaminase gene family from human keratinocytes: Detection and identification of transglutaminase gene products based on RT-PCR with degenerate primers. J. Biol. Chem., 273, 3452-3460.
16. Board, P.G., Losowsky, M.S. and Miloszewski, K.J. (1993). Factor XIII: Inherited and acquired deficiency. Blood Rev., 7, 229-242.
17. Ichinose, A., Tomonori, I. and Hashiguchi, T. (1996). The normal and abnormal genes of the a and b subunits in coagulation factor XIII. Sem. Thromb. Hemostasis, 22, 385-391.
18. Mikkola, H. and Palotie, A. (1996). Gene defects in congenital factor XIII deficiency. Sem. Thromb. Hemostasis, 22, 393-398.
19. Huber, M., Rettler, I., Bernasconi, K., Frenk, E., Lavrijsen, S.P.M., Ponce, M., Bon, A., Lautenschlager, S., Schorderet, D.F. and Hohl, D. (1995). Mutations of keratinocyte transglutaminase in lamellar ichthyosis. Science, 267, 525-528.
20. Russell, L.J., DiGiovanna, J.J., Rogers, G.R., Steinert, P.M., Hashem, N., Compton, J.G. and Bale, S.K. (1995). Mutations in the gene for transglutaminase I in autosomal recessive lamellar ichthyosis. Nature Genetics, 9, 279-283.
21. Kim, S.Y., Chung, S.-L. and Steinert, P.M. (1995). Highly active soluble processed forms of the TGase I enzyme in epidermal keratinocytes. J. Biol. Chem., 270, 18 026-18 035.
22. Steinert, P.M., Kim, S.Y., Chung, S.I. and Marekov, L.N. (1996). The transglutaminase 1 enzyme is variably acylated by myristate and palmitate during differentiation in epidermal keratinocytes. J. Biol. Chem., 271, 26 242-26 250.
23. Esposito, C., Puccim P., Amoresanom A., Marino, G., Cozzolino, A. and Porta, R. (1996). Transglutaminase from rat coagulating gland secretion Post-translational modifications and activation by phosphatidic acids. J. Biol. Chem., 271, 27 416-27 423.
24. Thomazy, V. and Fesus, L. (1989). Differential expression of tissue transglutaminase in human cells. Cell Tissue Res., 255, 215-224.
25. Aeschlimann, D. and Paulsson, M. (1991). Crosslinking of laminin-nidogen complexes by tissue transglutaminase: A novel mechanism for basement membrane stabilization. J. Biol. Chem., 266, 15 308-15 317.
26. Aeschlimann, D., Wetterwald, A., Fleisch, H. and Paulsson, M. (1993). Expression of tissue transglutaminase in skeletal tissue correlates with events of terminal differentiation of chondrocytes. J. Cell Biol., 120, 1461-1470.
27. Muszbek, L., Adany, R. and Mikkola, H. (1996). Novel aspects of blood coagulation factor XIII: Structure, distribution, activation, and function. CRC Crit. Rev. Clin. Lab. Sci., 33, 357-421.
28. Mosesson, M.W. (1997). Fibrinogen and fibrin polymerization: Appraisal of the binding events that accompany fibrin generation and fibrin clot assembly. Blood Coag. Fibrinol., 8, 257-267.
29. Knox, P., Crooks, S. and Rimmer, C.S. (1986). Role of fibronectin in the migration of fibroblasts into plasma clots. J. Cell Biol., 102, 2318-2323.
30. Mosher, D.F., Fogerty, F.J. Chernousov, M.A. and Barry, E.L. (1991). Assembly of fibronectin into extracellular matrix. Ann. NY Acad. Sci., 614, 167-180.
31. Ueki, S., Takagi, J. and Saito, Y. (1996). Dual functions of transglutaminase in novel cell adhesion. J. Cell Sci., 109, 2727-2735.
32. Corbett, S.A., Lee, L., Wilson, C.L. and Schwarzbauer, J.E. (1997). Covalent crosslinking of fibronectin to fibrin is required for maximal cell adhesion to a fibronectin fibrin matrix. J. Biol. Chem., 212, 24 999-25 005.
33. Sheetz, M.P., Felsenfeld, D.P. and Galbraith, C.G. (1998). Cell migration: Regulation of force on extracellular-matrix integrin complexes. Trends Cell Biol., 8, 51-54.
34. Reichert, U., Michel, S. and Schmidt, R. (1993). "The cornified cell envelope: A key structure of terminally differentiating keratinocytes." In: Molecular Biology of the Skin, edited by M. Darmon and M. Blumberg, pp. 107-150, San Diego, CA: Academic Press, Inc.
35. Kim, I.G., Gorman, J.J., Park, S.C., Chung, S.I. and Steinert, P.M. (1993). The deduced amino acid sequence of the novel protransglutaminase E (TGase 3) of human and mouse. J. Biol. Chem., 268, 12 682-12 690.
36. Steinert, P.M. and Marekov, L.N. (1995). The proteins elafin, filaggrin, keratin intermediate filaments, loricrin, and small proline-rich proteins 1 and 2 are isopeptide crosslinked components of the human epidermal cornified cell envelope. J. Biol. Chem., 270, 17 702-17 711.
37. Steinert, P.M. and Marekov, L.N. (1997) Direct evidence that involucrin is a major early isopeptide crosslinked component of the keratinocyte cornified cell envelope. J. Biol. Chem., 272, 2021-2030.
38. Robinson, N.A., Lapic, S., Welter, J.K. and Eckert, R.L. (1997) S100A11, S100A10, annexin I, desmosomal proteins, small prolinr-rich proteins, plasminogen activator inhibitor-2, and involucrin are components of the cornified envelope of cultured human epidermal keratinocytes. J. Biol. Chem., 272, 12 035-12 046.
39. Candi, E., Taresa, E., Idler, W.W., Kartasova, T., Marekov, L.N. and Steinert, P. (1999). Transglutaminase cross-linking properties of the small proline rich 1 family of cornified cell envelope proteins: Integration with loricrin. J. Biol. Chem., 274, 7226-7237.
40. Matsuki, M., Yamashita, F., Ishida-Yamamoto, A., Yamada, K., Kinoshita, C. Fushiki, S., Ueda, E., Morishima, Y., Tabata, K., Yasuno, H., Hashida, M., Iizuka, H., Ikawa, M., Okabe, M., Kondoh, G., Kinoshita, T., Takeda, J. and Yamanishi, K. (1998). Defective stratum corneum and early neonatal death in mice lacking the gene for transglutaminase 1 (keratinocyte transglutaminase). Proc. Natl. Acad. Sci. USA, 95, 1044-1049.
41. Dubbink, H.J., Verkaik, N.S., Faber, P.W., Trapman, J., Schröder, F.H. and Romijn, J.C. (1996). Tissue-specific and androgen-regulated expression of human prostate-specific transglutaminase. Biochem, J., 315, 901-908.
42. Cohen, C.M., Dolimas, E. and Korsgren, C. (1993). Human erythrocyte membrane protein band 4.2. Semin. Hematol., 30, 119-137.
43. Gwynn, B., Korsgren, C., Cohen, C.M., Ciciotte, S.L. and Peters, L.L. (1997). The gene encoding protein 4.2 is distinct from the mouse platelet storage pool deficiency mutation pallid. Genomics, 42, 532-535.
44. Yee, V.C., Pedersen, L.C., Le Trong, I., Bishop, P.D., Stenkamp, R.E. and Teller, D.C. (1994). Three-dimensional structure of a transglutaminase: Human blood coagulation factor XIII. Proc. Natl. Acad. Sci. USA, 91, 7296-7300.
45. Yee, V.C., Le Trong, I., Bishop, P.D., Pedersen, L.C., Stenkamp, R.E. and Teller, D.C. (1996). Structure and function studies of factor XIIIa by X-ray crystallography. Sem. Thromb. Hemostasis, 22, 377-384.
46. Pedersen, L.C., Yee, V.C., Bishop, P.D., Le Trong, I., Teller, D.C., Stenkamp, R.F. (1994). Transglutaminase factor XIII uses proteinase-like catalytic triad to crosslink macromolecules. Protein Sci., 3, 1131-1135.
47. Micanovic, R., Procyk, R., Lin, W. and Matsueda, G.R. (1994). Role of histidine 373 in the catalytic activity of coagulation factor XIII. J. Biol. Chem., 269, 9190-9194.
48. Cariello, L., Zanetti, L. and Lorand, L. (1994). Effects of inhibiting transglutaminase during egg fertilization and development. Biochem. Biophys. Res. Commun., 205, 565-569.
49. Mukherjee, A.B., Cordella-Miele, E., Kikukawa, T. and Miele, L. (1988). Modulation of cellular response to antigens by uteroglobin and transglutaminase. Adv. Exp. Med. Biol., 231, 135-152.
50. Aeschlimann, D., Kaupp, O. and Paulsson, M. (1995). Transglutaminase-catalyzed matrix crosslinking in differentiating cartilage: Identification of osteonectin as a major glutaminyl substrate. J. Cell Biol., 129, 881-892.
51. Thomázy, V.A. and Davies, P.J.A. (1999). Expression of tissue transglutaminase in the developing chicken limb is associated both with apoptosis and endochondral ossification. Cell Death Differ., 6, 146-154.
52. Iwai, N., Shimoike, H. and Kinoshita, M. (1995). Genes up-regulated in hypertrophied ventricle. Biochem. Biophys. Res. Commun., 209, 527-534.
53. Schittny, J.C., Paulsson, M., Vallan, C., Burri, C., Kedei, N. and Aeschlimann, D. (1997). Protein crosslinking mediated by tissue transglutaminase correlates with the maturation of extracellular matrices during lung development. Am. J. Respir. Cell Mol. Biol., 17, 334-343.
54. c during the prenatal development of human submandibular glands. J. Dental Res., 74, 1812-1816.
55. Hand, D., Perry, M.J. and Haynes, L.W. (1993). Cellular transglutaminase in neural development. Int. J. Dev. Neurosci., 11, 709-720.
56. Nagy, L., Thomázy, V.A., Chandraratna, R.A., Heyman, R.A. and Daviesm P.J.A. (1996). Retinoid-regulated expression of bcl-2 and tissue transglutaminase during differentiation and apoptosis of human myeloid leukemia (HL-60) cells. Leukemia Res., 20, 499-505.
57. Shimizu, T., Takao, T., Hozumi, K., Nunomura, K., Ohta, S., Shimonishi, V. and Ikegami, S. (1997). Structure of a covalently crosslinked form of core histones present in the starfish sperm. Biochemistry, 36, 12 0701-12 079.
58. Nagy, L., Thomázy, V.A., Saydak, M.M., Stein, P. and Davies, P.J.A. (1997). The promoter of the mouse tissue transglutaminase gene directs tissue-specific, retinoid-regulated and apoptosis-linked expression. Cell Death Diff., 4, 534-547.
59. Nemes Jr., Z., Friis, R.R., Aeschlimann, D., Saurer, S., Paulsson, M. and Fésüs, L. (1996). Expression and activation of tissue transglutaminase in apoptotic cells of involuting rodent mammary tissue. Eur. J. Cell Biol., 70, 125-133.
60. Guenette, R.S., Daehlin, L., Mooibroek, M., Wong, K. and Tenniswood, M. (1994). Thanatogen expression during involution of the rat ventral prostate after castration. J. Androl., 15, 200-211.
61. Raghunath, M., Höpfner, B., Aeschlimann, D., Lüthi, U., Meuli, M., Altermatt, S., Gobet, R., Bruckner-Tuderman, L. and Steinmann, B. (1996). Crosslinking of the dermoepidermal junction of skin regenerating from keratinocyte autografts. J. Clin. Invest., 98, 1174-1184.
62. Valenzuela, R., Shainoff, J.R., DiBello, P.M., Urbanic, D.A., Anderson, J.M., Matsueda, G.R. and Kudryk, B.J. (1992). Immunoelectrophoretic and immunohistochemical characterizations of fibrinogen derivatives in artherosclerotic aortic intimas and vascular prosthesis pseudo-intimas. Am. J. Pathol., 141, 861-880.
63. Bowness, J.M., Venditti, M., Tarr, A.H. and Taylor, J.R. (1994). Increase in ε(γ-glutamyl)lysine crosslinks in artherosclerotic aortas. Artherosclerosis, 111, 247-253.
64. Mirza, A., Liu, S.-L., Frizell, E., Zhu, J., Maddukuri, S., Martinez, J., Davies, P., Schwarting, R., Norton, P. and Zern, M.A. (1997). A role for tissue transglutaminase in hepatic injury and fibrogenesis, and its regulation by NF-κB. Am. J. Physiol., 272, G281-G288.
65. Johnson, T.S., Griffin, M., Thomas, G.L., Skill, J., Cox, A., Yang, B., Nicholas, B., Birckhichler, P.J., Muchaneta-Kubara, C. and El Nahas, A.M. (1997). The role of transglutaminase in the rat subtotal nephrectomy model of renal fibrosis. J. Clin. Invest., 99, 2950-2960.
66. Barsigian, C., Stern, A.M. and Martinez, J. (1991). Tissue (type II) transglutaminase covalently incorporates itself, fibrinogen, or fibronectin into high molecular weight complexes on the extracellular surface of isolated hepatocytes. J. Biol. Chem., 266, 22 501-22 509.
67. Martinez, J., Chalupowicz, D.G., Roush. R.K., Sheth, A. and Barsigian, C. (1994). Transglutaminase-mediated processing of fibronectin by endothelial cell monolayers. Biochemistry, 33, 2538-2545.
68. Verderio, E., Nicholas, B., Gross, S. and Griffin, M. (1998). Regulated expression of tissue transglutaminase in Swiss 3T3 fibroblasts: Effects on the processing of fibronectin, cell attachment, and cell death. Exp. Cell Res., 239, 119-138.
69. Tyrrell, D.J., Sale, W.S. and Slife, C.W. (1988). Fibronectin is a component of the sodium dodecyl sulfate-insoluble transglutaminase substrate. J. Biol. Chem., 263, 8464-8469.
70. Kinsella, M.G. and Wight, T.N. (1990). Formation of high molecular weight dermatan sulfate proteoglycan in bovine aortic endothelial cell cultures. J. Biol. Chem., 265, 17 891-17 898.
71. Bendixen, E., Borth, W. and Harpel, P.C. (1993). Transglutaminases catalyze crosslinking of plasminogen to fibronectin and human endothelial cells. J. Biol. Chem., 268, 21 962-21 967.
72. Kleman, J.-P., Aeschlimann, D., Paulsson, M. and van der Rest, M. (1995). Transglutaminase-catalyzed crosslinking of fibrils of collagen V/XI in A204 rhabdomyosarcoma cells. Biochemistry, 34, 13 768-13 775.
73. Gaudry, C.A., Verderio, E., Aeschlimann, D., Cox, A., Smith, C. and Griffin, M. (1999). Cell surface localization of tissue transglutaminase is dependent on a fibronectin binding site in its N-terminal β-sandwich domain. J. Biol. Chem., 274, 30 707-30 714.
74. Aeschlimann, D., Aeschlimann, P. and Mosher, D.F. (1996). Monitoring of tissue transglutaminase localization in cellular events by expressing the enzyme as a fusion protein with green fluorescent protein. Proceedings of the Fifth International Conference on Transglutaminase and Protein Crosslinking Reactions, p. 47.
75. Gentile, V., Thomazy, V., Piacentini, M., Fésus, L. and Davies, P.J.A. (1992). Expression of tissue transglutaminase in Balb-c 3T3 fibroblasts: Effect on cellular morphology and adhesion. J. Cell Biol., 119, 463-474.
76. Jones, R.A., Nicholas, B., Mian, S., Davies, P.J.A. and Griffin, M. (1997). Reduced expression of tissue transglutaminase in a human endothelial cell line leads to changes in cell spreading, cell adhesion and reduced polymerisation of fibronectin. J. Cell Sci., 110, 2461-2472.
77. Johnson, T.S., Knight, C.R.L., El-Alaoui, S., Mian, S., Rees, R.C., Gentile, V., Davies, P.J.A. and Griffin, M. (1994). Transfection of tissue transglutaminase into highly malignant hamster fibrosarcoma leads to a reduced incidence of primary tumour growth. Oncogene, 9, 2935-2942.
78. Upchurch, H.F., Conway, E., Patterson Jr., M.K. and Maxwell, M.D. (1991). Localization of cellular transglutaminase on the extracellular matrix after wounding: Characteristics of the matrix bound enzyme. J. Cell Physiol., 149, 375-382.
79. LeMosy, E.K., Erickson, HP., Beyer, W.F., Radek, J.T., Jeong, J.M. Murthy, S.N.P. and Lorand, L. (1992). Visualization of purified fibronectin-transglutaminase complexes. J. Biol. Chem., 267. 7880-7885.
80. Jeong, J.-M., Murthy, S.N.P., Radek, J.T. and Lorand, L. (1995). The fibronectin-binding domain of transglutaminase. J. Biol. Chem., 270, 5654-5658.
81. Aeschlimann, D., Mosher, D.F. and Paulsson, M. (1996). Tissue transglutaminase and factor XIII in cartilage and bone remodelling. Sem. Thromb. Hemostasis, 22, 437-443.
82. 125FAK accompanies cell adhesion to extracellular matrix: A role in cytoskeletal assembly. J. Cell Biol., 119, 893-903.
83. Miyamoto, S., Akiyama, S.K. and Yamada, K.M. (1995). Synergistic roles for receptor occupancy and aggregation in integrin transmembrane function. Science, 267, 883-885.
84. Morla, A., Zhang, Z., Ruoslahti, E. (1994). Superfibronectin is a functionally distinct form of fibronectin. Nature, 367, 193-196.
85. 2-terminal region of fibronectin to molecules of large apparent molecular mass. J. Biol. Chem., 271, 33 284-33 292.
86. C-catalyzed modification. J. Biol. Chem., 270, 23 415-23 420.
87. Zhang, Q., Magnusson, M.K. and Mosher, D.F. (1997). Lysophosphatidic acid and microtubule-destabilizing agents stimulate fibronectin assembly through Rho-dependent actin stress fiber formation and cell contraction. Mol. Biol. Cell, 8, 1415-1425.
88. Chowdhury, Z.A., Barsigian, C., Chalupowicz, G.D., Bach, T.L., Garcia-Manero, G. and Martinez, J. (1997). Colocalization of tissue transglutaminase and stress fibers in human vascular smooth muscle cells and human umbilical vein endothelial cells. Exp. Cell Res., 231, 38-49.
89. Im, M.J., Russell, M.A. and Feng, J.F. (1997). Transglutaminase II: A new class of GTP-binding protein with new biological functions. Cell Signalling, 9, 477-482.
90. h: A GTP-binding protein with transglutaminase activity and receptor signaling function. Science, 264, 1593-1596.
91. Greenberg, C.S., Achyuthan, K.E., Borowitz, M.J. and Shuman, M.A. (1987). The transglutaminase in vascular cells and tissues could provide an alternative pathway for fibrin stabilization. Blood. 70, 702-709.
92. Shainoff, J.R., Urbanic, D.A. and DiBello, P.M. (1991). Immunoelectrophoretic characterization of the crosslinking of fibrinogen and fibrin by factor XIIIa and tissue transglutaminase. J. Biol. Chem., 266, 6429-6437.
93. Borth, W., Chang, V., Bishop, P. and Harpel, P.C. (1991). Lipoprotein (a) is a substrate for factor XIIIa and tissue transglutaminase. J. Biol. Chem., 266, 18 149-18 153.
94. Rosenblatt, S., Bassuk, J.A., Alpers, C.E., Sage, E.H., Timpl, R. and Preissner, K.T. (1997). Differential modulation of cell adhesion by interaction between adhesive and counter-adhesive proteins: Characterization of the binding of vitronectin to osteonectin (BM40, SPARC). Biochem. J., 324, 311-319.
95. 726 in nidogen as the amine acceptor in transglutaminase-catalyzed cross-linking of laminin-nidogen complexes. J. Biol. Chem., 267, 11 316-11 321.
96. Behrendt, N., Ronne, E. and Dano, K. (1993). A novel specific pro-urokinase complex on monocyte-like cells, detected by transglutaminase-catalyzed crosslinking. FEBS Lett., 336, 394-406.
97. Bendixen, E., Harpel, P.C. and Sottrup-Jensen, L. (1995). Location of the major ε-(γ-glutumyl)lysyl crosslinking site in transglutaminase-modified human plasminogen. J. Biol. Chem., 270, 17 929-17 933.
98. 86, essential for transglutaminase-mediated crosslinking. J. Biol. Chem., 269, 15 394-15 398.
99. Raghunath, M., Bächi, T., Aeschlimann, D. and Steinmann, B. (1996). 10-12 nm microfibrils and their main component, fibrillin, are crosslinked by transglutaminase in dermal fibroblast cultures and human dermis. Arch. Dermatol. Res., 288, 282.
100. Qian, R.-Q. and Glanville, R.W. (1997). Alignment of fibrillin molecules in elastic microfibrils is defined by transglutaminase-derived crosslinks. Biochemistry, 36, 15 841-15 847.
101. Raghunath, M., Unsold, C., Kubitscheck, U., Bruckner-Tuderman, L., Peters, R. and Meuli, M. (1998). The cutaneous microfibrillar apparatus contains latent transforming growth factor-β binding protein-1 (LTBP-1) and is a repository for latent TGF-β1. J. Invest. Dermatol., 111, 559-564.
102. Mehul, B., Bawumia, S. and Hughes, C. (1995). Crosslinking of galectin-3, a galactose-binding protein of mammalian cells, by tissue transglutaminase. FEBS Lett., 360, 160-164.
103. Lohnes, D., Mark, M., Mendelsohn, C., Dolle, P., Decimo, D., Le Meur, M., Dierich, A., Gorry, P. and Chambon, P. (1995). Developmental roles of the retinoic acid receptors. J. Steroid Biochem. Mol. Biol., 53, 475-486.
104. Cash, D.E., Bock, C.B., Schugart, K., Linney, E. and Underhill, T.M. (1997). Retinoic acid receptor α function in vertebrate limb skeletogenesis: A modulator of chondrogenesis. J. Cell Biol., 136, 445-457.
105. Nagy, L., Saydak, M., Shipley, N., Lu, S., Basilion, J.P., Yan, Z.H., Syka, P., Chandraratna, R.A.S., Stein, J.P., Heyman, R.A. and Davies, P.J.A. (1996). Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response clement) in the mouse tissue transglutaminase gene promoter. J. Biol. Chem., 271, 4355-4365.
106. Borge, L., Demignot, S. and Adolphe, M. (1996). Type II transglutaminase expression in rabbit articular chondrocytes in culture: Relation with cell differentiation, cell growth, cell adhesion, and cell apoptosis. Biochim. Biophys. Acta, 1312, 117-124.
107. Suto, N., Ikura, K. and Sasaki, R. (1993). Expression induced by interleukin-6 of tissue-type transglutaminase in hepatoblastoma HepG2 cells. J. Biol. Chem., 268, 7469-7473.
108. Ritter, S.J. and Davies, P.J.A. (1998). Identification of a transforming growth factor-β1/bone morphogenetic protein 4 (TGF-β1/BMP4) response element within the mouse tissue transglutaminase gene promoter. J. Biol. Chem., 273, 12 798-12 806.
109. Nurminskaya, M., Magee, C., Nurminsky, D. and Linsenmayer, T.F. (1998). Plasma transglutaminase in hypertrophic chondrocytes: Expression and cell-specific intracellular activation produce cell death and externalization. J. Cell Biol., 142, 1135-1144.
110. Slife, C.W., Morris, G.S. and Snedeker, S.W. (1987). Solubilization and properties of the liver plasma membrane transglutaminase. Arch. Biochem. Biophys., 257, 39-47.
111. Harsfalvi, J., Arato, G. and Fésus, L. (1987). Lipids associated with tissue transglutaminase. Biochim. Biophys. Acta, 923, 42-45.
112. Aeschlimann, D. and Wetterwald, A. (1998). Transglutaminase crosslinking of bone matrix: Isolation of a cDNA encoding a novel human transglutaminase. Trans. Orthop. Res. Soc., 23, 310.
113. 3 integrin. J. Bone Min. Res. (in press).
114. Taresa, E., Kedei, N., Thomazy, V. and Fésus, L. (1992). An involucrin-like protein in hepatocytes serves as a substrate for tissue transglutaminase during apoptosis. J. Biol. Chem., 267, 25 648-25 651.
115. Fésus, L., Madi, Z., Balajthy, Z., Nemes, Z. and Szondy, Z. (1996). Transglutaminase induction by various cell death and apoptosis pathways. Experientia, 52, 942-949.
116. Melino, G. and Piacentini, M. (1998). "Tissue" transglutaminase in cell death: A downstream or a multifunctional upstream effector? FEBS Lett., 430, 59-63.
117. Lorand, L. (1996). Neurodegenerative diseases and transglutaminase. Proc. Natl. Acad. Sci. USA, 93, 14 310-14 313.
118. Igarashi, S., Koide, R., Shimohata, T., Yamada, M., Hayashi, Y., Takano, H., Date, H., Oyake, M., Sato, T., Sato, A., Egawa, S., Ikeuchi, T., Tanaka, H., Nakano, R., Tanaka, K., Hozumi, I., Inuzuka, T., Takahashi, H. and Tsuji, S. (1998). Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch. Nature Genet., 18, 111-117.
119. Murthy, S.N.P., Wilson, J., Zhang, Y. and Lorand, L. (1994). Residue Gln-30 of human erythrocyte anion transporter is a prime site for reaction with intrinsic transglutaminase. J. Biol. Chem., 269, 22 907-22 911.
120. Clément, S., Velasco, P.T., Murthy, S.N.P., Wilson, J.H., Lukas, T.J., Goldman, R. and Lorand, L. (1998). The intermediate filament protein, vimentin, in the lens is a target for crosslinking by transglutaminase. J. Biol. Chem., 273, 7604-7609.
121. Selkoe, D.J., Abraham, C. and Ihara, Y. (1982). Brain transglutaminase: In vitro crosslinking of human neurofilament proteins into insoluble polymers. Proc. Natl. Acad. Sci. USA, 79, 6070-6074.
122. Dudek, S.M. and Johnson, G.V.M. (1993). Transglutaminase catalyzes the formation of sodium dodecyl sulfate-insoluble, Alz-50-reactive polymers of τ. J. Neurochem., 61, 1159-1162.
123. Kahlem, P., Green, H. and Djian, P. (1988). Transglutaminase action imitates Huntington's disease: Selective polymerization of huntingtin containing expanded polyglutamine. Mol. Cell, 1, 595-601.
124. Nemes Jr., Z., Adány, R., Balázs, M., Boross, P. and Fésüs, L. (1997). Identification of cytoplasmic actin as an abundant glutaminyl substrate for tissue transglutaminase in HL-60 and U937 cells undergoing apoptosis. J. Biol. Chem., 272, 20 577-20 583.
125. Umar, S., Malavasi, F. and Mehta, K. (1996). Posttranslational modification of CD38 protein into high molecular weight form alters its catalytic properties. J. Biol. Chem., 271, 15 922-15 927.
126. Trejo-Skalli, A.V., Velasco, P.T., Murthy, S.N.P., Lorand, E. and Goldman, R. (1995). Association of a transglutaminase-related antigen with intermediate filaments. Proc. Natl. Acad. Sci. USA, 92, 8940-8944.
127. Kang, S.J., Shin, K.S., Song, W.K., Ha, D.B., Chung, C.H. and Kang, M.-S. (1995). Involvement of transglutaminase in myofibril assembly of chick embryonic myoblasts in culture. J. Cell Biol., 130, 1127-1136.
128. Steinhardt, R.A., Guoqiang, B. and Alderton, J.M. (1993). Cell membrane resealing by a vesicular mechanism similar to neurotransmitter release. Science, 263, 390-393.
129. Kochhar, D.M., Jiang, H., Harnish, D.C. and Soprano, D.R. (1993). Evidence that retinoic acid-induced apoptosis in the mouse limb bud core mesenchynial cells is gene-mediated. Prog. Clin. Biol. Res., 383B, 815-825.
130. Dupé, V., Ghyselinck, N.B., Thomazy, V., Nagy, L., Davies, P.J.A., Chambon, P. and Mark, M. (1999). Essential roles of retinoic acid signalling in interdigital apoptosis and control of BMP-7 expression in mouse autopods. Dev. Biol., 208, 30-43.
131. Zhang, L.X., Mills, K.J., Dawson, M.I., Collins, S.J. and Jetten, A.M. (1995). Evidence for the involvement of retinoic acid receptor RARα-dependent signaling pathway in the induction of tissue transglutaminase and apoptosis by retinoids. J. Biol. Chem., 270, 6022-6029.
132. Monczak, Y., Trudel, M., Lamph, W.W. and Miller Jr., W.H. (1997). Induction of apoptosis without differentiation by retinoic acid in PLB-985 cells requires the activation of both RAR and RXR. Blood, 90, 3345-3355.
133. 3 integrin-mediated endothelial cell survival. J. Cell Biol., 141, 1083-1093.
134. Kunico, G.S., Tsyganskaya, M., Zhu, J., Liu, S.-L., Nagy, L., Thomazy, V., Davies, P.J.A. and Zern, M.A. (1998). TNF-α modulates expression of the tissue transglutaminase gene in liver cells. Am. J. Physiol., 274, G240-G245.
135. Beg, A.A., Sha, W.C., Bronson, R.T., Ghosh, S. and Baltimore, D. (1995). Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature, 376, 167-170.
136. Benedetti, L., Grignani, F., Scicchitano, B.M., Jetten, A.M., Diverio, D., Lo Coco, F., Avvisati, G., Gambacorti-Passerini, C., Adamo, S., Levin, A.A., Pelicci, P.G. and Nervi, C. (1996). Retinoid-induced differentiation of acute promyelocytic leukemia involves PML-RAR-α-mediated increase of type II transglutaminase. Blood, 87, 1939-1950.
137. Mehta, K., McQueen, T., Neamati, N., Collins, S. and Andreeff, M. (1996). Activation of retinoid receptors RAR-α and RXR-α induces differentiation and apoptosis, respectively, in HL-60 cells. Cell Growth Diff., 7, 179-186.
138. Joseph, B., Lefebvre, O., Mereau-Richard, C., Danze, P.M., Belin-Plancot, M.T. and Formstecher, P. (1998). Evidence for the involvement of both retinoic acid receptor-and retinoic X receptor-dependent signalling pathways in the induction of tissue transglutaminase and apoptosis in the human myeloma cell line RPMI 8226. Blood, 91, 2423-2432.
139. 19F-NMR spectroscopy. Biochim. Biophys. Acta, 1270, 52-57.
140. h (transglutaminase II)-mediated signaling. J. Biol. Chem., 271, 16 451-16 454.
141. h is subtype specific and independent of its transglutaminase activity. J. Biol. Chem., 271, 32 385-32 391.
142. h hydrolyzes GTP and ATP. Biochemstry, 36, 11 655-11 664.
143. h (transglutaminase II) with phospholipase C. J. Biol. Chem., 270, 27 058-27 062.
144. Lu, S., Saydak, M., Gentile, V., Stein, J.P. and Davies, P.J.A. (1995). Isolation and characterization of the human tissue transglutaminase gene promoter. J. Biol. Chem., 270, 9748-9756.
145. Verma, A.K., Shoemaker, A., Simsiman, R., Denning, M. and Zachman, R.D (1992). Expression of retinoic acid nuclear receptors and tissue transglutaminase is altered in various tissues of rats fed a vitamin A-deficient diet. J. Nutr., 122, 2144-2152.
146. Ahuja, H.S., James, W. and Zakeri, Z. (1997). Rescue of the limb deformity in hammertoe mutant mice by retinoic acid-induced cell death. Dev. Dyn., 208, 466-481.
147. Suto, N., Ikura, K. and Sasaki, R. (1993). Expression induced by interleukin-6 of tissue-type transglutaminase in hepatoblastoma HepG2 cells. J. Biol. Chem., 268, 7469-7473.
148. Ikura, K., Shinagawa, R., Suto, N. and Sasaki, R. (1994). Increase caused by interleukin-6 in promoter activity of guinea pig liver transglutaminase gene. Biosci. Biotechnol. Biochem., 58, 1540-1541.
149. Franchimont, N., Rydziel, S. and Canalis, E. (1997). Interleukin-6 is autoregulated by transcriptional mechanisms in cultures of rat osteoblastic cells. J. Clin. Invest., 100, 1797-1803.
150. Weinberg, J.B., Pippen, A.M. and Greenberg, C.S. (1991). Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis. Arthritis Rheum., 34, 996-1005.
151. Hettasch, J.M., Bandarenko, N., Burchette, J.L., Lai, T.S., Marks, J.R., Haroon, Z.A., Peters, K., Dewhirst, M.W., Iglehart, J.D. and Greenberg, C.S. (1996). Tissue transglutaminase expression in human breast cancer. Lab. Invest., 75, 637-645.
152. Grenard, P., Bresson-Hadni, S., Vuitton, D.A. and Ricard-Blum, S. (1999). Crosslinking by transglutaminase stabilizes the extracellular matrix of fibrotic liver. Proceedings of the XVIth Meeting of the Federation of the European Connective Tissue Societies, C10.
153. Frizell, E., Liu, S.-L., Abraham, A., Ozaki, I., Eghbali, M., Sage, E.H. and Zern, M.A. (1995). Impression of SPARC in normal and fibrotic livers. Hepatology, 21, 847-854.
154. Neri, M., Descalzi-Cancedda, F. and Cancedda, R. (1992). Heat-shock response in cultured chick embryo chondrocytes: Osteonectin is a secreted heat-shock protein. Eur. J. Biochem., 205, 569-574.
155. Kahlem, P., Terré, C., Green, H. and Djian, P. (1996). Peptides containing glutamine repeats as substrates for transglutaminase-catalyzed crosslinking: Relevance to diseases of the nervous system. Proc. Natl. Acad. Sci. USA, 93, 14 580-14 585.
156. Cooper, A.J.L. Sheu, K.-F.R., Burke, J.R., Onodera, O., Strittmatter, W.J., Roses, A.D. and Blass, J.P. (1997). Transglutaminase-catalyzed inactivation of glyceraldehyde-3-phosphate dehydrogenase and α-ketoglutarate dehydrogenase complex by polyglutamine domains of pathological length. Proc. Natl. Acad. Sci. USA, 94, 12 604-12 609.
157. Johnson, G.V.W., Cox, T.M., Lockhart, J.P., Zinnerman, M.D., Miller, M.L. and Powers, R. (1997). Transglutaminase activity is increased in Alzheimer's disease brain. Brain Res., 751, 323-329.
158. Dietrich, W., Ehnis, T., Bauer, M., Donner, P., Volta, U., Riecken, E.O. and Schuppan, D. (1997). Identification of tissue transglutaminase as the autoantigen of celiac disease. Nature Med., 3, 797-801.
159. Sollid, L.M., Molberg, O., McAdam, S. and Lundin, K.E.A. (1997). Autoantibodies in coeliac disease: Tissue transglutaminase guilt by association? Gut, 41, 851-852.
160. Hager, H., Jensen, P.H., Hamilton-Dutoit, S., Neilsen, M.S., Birckbichler, P. and Gliemann, J. (1997). Expression of tissue transglutaminase in human bladder carcinoma. J. Pathol., 183, 398-403.
161. Schenker, T. and Trueb, B. (1996). Tissue transglutaminase in mesenchymal tumour cells. Apoptosis, 1, 126-130.
162. Piacentini, M., Piredda, L., Starace, D., Annicchiarico-Petruzzelli, M., Mattei, M., Oliverio, S., Farrace, M.G. and Melino, G. (1996). Differential growth of N-and S-type human neuroblastoma cells xenografted into SCID mice: Correlation with apoptosis. J. Pathol., 180, 415-422.
163. Martinowitz, U. and Saltz, R. (1996). Fibrin sealant. Curr. Opin. Hematol., 3, 395-402.
164. Karges, H.E. and Metzner, H.J. (1996). Therapeutic factor XIII preparations and perspectives for recombinant factor XIII. Sem. Thromb. Hemostasis, 22, 427-436.
165. Wozniak, G., Dapper, F. and Alemany, J. (1996). Factor XIII in ulcerative leg disease: Background and preliminary clinical results. Sem. Thromb. Hemostasis, 22, 445-450.
166. Jürgensen, K., Aeschlimann, D., Cavin, V., Genge, M. and Hunziker, E.B. (1997). A new biological glue for cartilage cartilage interfaces: Tissue transglutaminase. J. Bone Joint Surg., 79-A, 185-193.
167. Eitan, S., Solomon, A., Lavie, V., Yoles, E., Hirschberg, D.L., Belkin, M. and Schwartz, M. (1994). Recovery of visual response of injured adult rat optic nerves treated with transglutaminase. Science, 264, 1764-1768.
168. 2-plasmin inhibitor to fibrin. FEBS Lett., 153, 369-371.
169. Schense, J.C. and Hubbell, J.A. (1999). Crosslinking of exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconj. Chem., 10, 75-81.
170. Parameswaran, K.N., Velasco, P.T., Wilson, J. and Lorand, L. (1990). Labeling of γ-lysine crosslinking sites in proteins with peptide substrates of factor XIIIa and transglutaminase. Proc. Natl. Acad. Sci. USA, 87, 8472-8475.
171. Bulpitt, P. and Aeschlimann, D. (1999). New strategy for chemical modification of hyaluronic acid: Preparation of functionalized derivatives and their use in the formation of novel biocompatible hydrogels. J. Biomed. Mat. Res., 47, 152-169.
172. Sperinde, J.J. and Griffith, L.G. (1997). Synthesis and characterization of enzymatically-crosslinked poly(ethylene glycol) hydrogels. Macromolecules, 30, 5255-5264.
173. Sato, H., Ikeda, M., Suzuki, K. and Hirayama, K. (1996). Site-specific modification of interleukin-2 by the combined use of genetic engineering techniques and transglutaminase. Biochemistry, 35, 13 072-13 080.
174. Walker, A.M., Montgomery, D.W,. Saraiya, S., Ho, T.W.C., Garewal, H.S., Wilson, J. and Lorand, L. (1995). Prolactin immunoglobulin G complexes from human serum act as co-stimulatory ligands causing proliferation of malignant B lymphocytes. Proc. Natl. Acad. Sci. USA, 92, 3278-3282.
175. Ikura, K., Yokota, H., Sasaki, R. and Chiba, H. (1989). Determination of amino-and carboxyl-terminal sequences of guinea pig liver transglutaminase: Evidence for amino-terminal processing. Biochemistry, 28, 2344-2348.
176. Suto, N., Ikura, K., Shinagawa, R. and Sasaki, R. (1995). Identification of promoter region of guinea pig liver transglutaminase gene. Biochim. Biophys. Acta, 1172, 319-322.
177. Lu, S. and Davies, P.J.A. (1997). Regulation of the expression of the tissue transglutaminase gene by DNA methylation. Proc. Natl. Acad. Sci. USA, 94, 4692-4697.
178. Chen, P., Sapperstein, S.K., Choi, J.D. and Michaelis, S. (1997). Biogenesis of the Saccharomyces cerevisiae mating pheromone a-factor. J. Cell Biol., 136, 251-269.
179. Small, K., Feng, J.-F., Lorenz, J., Donnelly, E.T., Yu, A., Im, M.-J., Dorn, G.W. and Liggett, S.B. (1999). Cardiac specific overexpression of transglutaminase II (Gh) results in a unique hypertrophy phenotype independent of phospholipase C activation. J. Biol. Chem., 274, 21 291-21 296.
180. Feng, J.-F., Readon, M., Yadav, S.P. and Im, M.-J. (1999). Calreticulin down-regulates both GTP binding and transglutaminase activities of transglutaminase II. Biochemistry, 38, 10 743-10 749.
181. Haroon, Z.A., Hettasch, J.M., Lai, T.S., Dewhirst, M.W. and Greenberg, C.S. (1999). Tissue transglutaminase is expressed, active, and directly involved in rat dermal wound healing and angiogenesis. FASEB J., 13, 1787-1795.